Krishna Institute of Medical Sciences Ltd Share News: Latest Updates & Alerts

Krishna Institute of Medical Sciences Ltd

NSE: KIMS BSE: 543308

₹595.15

(-1.86)%

Sun, 08 Feb 2026, 10:58 pm

MTF 5xInvest in Krishna Institute of Medical Sciences Ltd with 5x Leverage Buy with MTF

Market Cap238.06B

PE Ratio79.20

Dividend0

Health Services

Hospital/Nursing Management

24.5K

krishna institute of medical s News

KIMS Reports Q3FY26 Results, Plans Rs 100 Cr Investment

Krishna Institute of Medical Sciences posted consolidated revenue of Rs 9,977 million in Q3FY26, up from Rs 7,724 million in Q3FY25. The company approved additional investment of up to Rs 100 crores in subsidiary Sarvejana Healthcare.

06 Feb 2026

co actions results

KIMS Shareholders Approve Related Party Transaction

Krishna Institute of Medical Sciences shareholders approved material related party transaction with subsidiary KIMS Hospital Bengaluru through postal ballot with 93.18% votes in favor.

03 Feb 2026

co actions results

KIMS Schedules Q3FY26 Results Conference Call

Krishna Institute of Medical Sciences announces earnings conference call on February 7, 2026, hosted by IIFL Capital to discuss Q3FY26 results and business strategy with senior management.

02 Feb 2026

co actions results

KIMS Seeks Shareholder Approval for ₹150 Cr Loan

Krishna Institute of Medical Sciences announces postal ballot for shareholder approval of material related party transaction involving ₹150 crore loan to subsidiary KIMS Hospital Bengaluru Private Limited.

02 Jan 2026

co actions results

KIMS Subsidiary Faces ₹12.42 Cr GST Demand Order

Krishna Institute of Medical Sciences' subsidiary Spanv Medisearch receives GST demand order worth ₹12.42 crores from Nagpur tax authorities for alleged non-payment on medicines for inpatients.

01 Jan 2026

stocks

Showing 1–5 of 43

Rows per page:

Market Current News

Godrej Agrovet Limited

Godrej Agrovet launches TAKAI insecticide for rice

Godrej Agrovet Limited launched TAKAI, a new insecticide for rice crops powered by Cyclapryn technology from ISK Japan, effective against Stem Borer and Leaf Folder pests.

08 Feb 2026

stocks

TINNA RUBBER AND INFRASTRUCTUR

Tinna Rubber Q3-9MFY26 Results Show Margin Expansion

Tinna Rubber reports stable revenue with EBITDA margins expanding by ~200 bps and PAT margins by ~110 bps in 9MFY26, driven by operational efficiency improvements and post-monsoon demand recovery.

08 Feb 2026

co actions results

HealthCare Global Enterprises

HCG Board to Consider Rights Issue on Feb 17

HealthCare Global Enterprises has scheduled a board meeting on February 17, 2026, to consider a fund raise proposal through rights issue of equity shares, with trading window closed from Feb 9-26.

08 Feb 2026

co actions results

ANUH PHARMA LTD.

Anuh Pharma Reports Strong Q3FY26 Financial Results

Anuh Pharma Limited published unaudited financial results for Q3FY26, showing revenue of ₹19,717.81 lakhs and net profit of ₹1,345.10 lakhs with improved margins.

08 Feb 2026

co actions results

NIMBUS PROJECTS LTD.

Nimbus Projects Approves Related Party Transactions

Nimbus Projects Limited successfully passed three special resolutions through postal ballot for material related party transactions involving joint venture partnership firms with 99.99% approval from shareholders.

08 Feb 2026

stocks

Showing 1–5 of 82486

Rows per page:

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800